MATERAZZI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 21.617
EU - Europa 9.822
AS - Asia 9.712
SA - Sud America 1.513
AF - Africa 497
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 43.182
Nazione #
US - Stati Uniti d'America 21.045
IT - Italia 4.101
SG - Singapore 3.257
CN - Cina 2.874
HK - Hong Kong 1.798
DE - Germania 1.405
SE - Svezia 1.304
BR - Brasile 1.300
BG - Bulgaria 659
GB - Regno Unito 538
VN - Vietnam 496
TR - Turchia 430
CA - Canada 426
FI - Finlandia 354
RU - Federazione Russa 335
FR - Francia 225
AT - Austria 220
CI - Costa d'Avorio 211
IN - India 208
UA - Ucraina 208
KR - Corea 148
NL - Olanda 114
SN - Senegal 100
JP - Giappone 97
CH - Svizzera 86
MX - Messico 79
BD - Bangladesh 69
AR - Argentina 63
PL - Polonia 49
IQ - Iraq 46
ZA - Sudafrica 46
ES - Italia 43
MA - Marocco 41
SA - Arabia Saudita 39
BE - Belgio 38
ID - Indonesia 38
NG - Nigeria 37
PK - Pakistan 35
EC - Ecuador 32
CO - Colombia 29
VE - Venezuela 25
CZ - Repubblica Ceca 23
CL - Cile 18
UZ - Uzbekistan 18
IR - Iran 17
PY - Paraguay 17
LT - Lituania 16
IL - Israele 15
JO - Giordania 15
EE - Estonia 14
IE - Irlanda 14
KE - Kenya 14
EG - Egitto 12
MY - Malesia 12
NP - Nepal 12
PE - Perù 12
PH - Filippine 12
TN - Tunisia 12
PT - Portogallo 10
RO - Romania 10
AL - Albania 9
AU - Australia 9
GR - Grecia 9
HN - Honduras 9
JM - Giamaica 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
TW - Taiwan 8
AZ - Azerbaigian 7
CR - Costa Rica 7
KG - Kirghizistan 7
OM - Oman 7
PA - Panama 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
KZ - Kazakistan 6
BJ - Benin 5
BY - Bielorussia 5
DK - Danimarca 5
LB - Libano 5
LK - Sri Lanka 5
RS - Serbia 5
BB - Barbados 4
GT - Guatemala 4
PS - Palestinian Territory 4
QA - Qatar 4
SV - El Salvador 4
AO - Angola 3
BH - Bahrain 3
EU - Europa 3
GA - Gabon 3
KW - Kuwait 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
CY - Cipro 2
Totale 43.143
Città #
Ashburn 2.388
Dallas 2.292
Woodbridge 1.786
Hong Kong 1.780
Fairfield 1.753
Singapore 1.735
Chandler 1.284
Houston 1.280
Ann Arbor 1.221
Santa Clara 1.084
Seattle 717
Milan 707
Shanghai 693
Sofia 647
Wilmington 607
Cambridge 605
Beijing 594
New York 508
Serra 402
Boardman 360
Los Angeles 337
Ottawa 336
Princeton 306
Lawrence 267
Izmir 255
Jacksonville 250
Munich 241
Florence 231
Medford 228
Abidjan 211
Hefei 208
Rome 208
Nanjing 200
Vienna 192
Pisa 174
London 153
Des Moines 152
Seoul 138
Dong Ket 132
Frankfurt am Main 127
São Paulo 124
Redondo Beach 123
Istanbul 120
Buffalo 116
Dearborn 111
San Diego 103
Turku 103
Dakar 100
Ho Chi Minh City 86
Tokyo 82
Bern 72
Bremen 66
Nanchang 64
Ogden 61
Redwood City 56
Naples 55
The Dalles 55
Kunming 54
Lancaster 53
Columbus 51
Helsinki 47
Jüchen 47
Hanoi 44
Hebei 44
Bologna 43
Changsha 43
Düsseldorf 43
Piscataway 43
Boulder 42
Chicago 40
Paris 40
Rio de Janeiro 40
Shenyang 39
San Jose 37
Atlanta 36
Council Bluffs 36
Guangzhou 36
Lucca 36
Phoenix 36
Falls Church 35
Washington 35
Brussels 34
Lagos 34
Warsaw 34
Belo Horizonte 33
Brooklyn 33
Fuzhou 33
San Francisco 33
Nuremberg 32
Cascina 31
Toronto 31
Jiaxing 30
Norwalk 30
Tianjin 29
Pune 28
Denver 26
Montreal 26
Poplar 25
Quanzhou 25
Brasília 24
Totale 29.857
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.092
Fistole del seno piriforme in un adolescente 898
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 323
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 308
Acquired Carotid-Jugular Fistula: Its Changing History and Management 253
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 236
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 235
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 229
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 223
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 219
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 213
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 211
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 211
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 210
Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. 209
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 207
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 206
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 205
Sorafenib in the treatment of thyroid cancer 203
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 203
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 202
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 201
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 200
Minimally invasive video-assisted thyroidectomy (MIVAT) from A to Z 198
Evaluation of a new ultrasonic device in thyroid surgery: comparative randomized study 196
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 196
Aggressive thyroid cancer: targeted therapy with sorafenib 194
Minimally invasive thyroidectomy in the treatment of well differentiated thyroid cancers: indications and limits 192
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 188
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 188
Energy-based devices in thyroid surgery-an overview 188
Sorafenib and Thyroid Cancer 187
A pandemic recap: lessons we have learned 187
Modified lateral neck lymphadenectomy: prospective randomized study comparing harmonic scalpel with clamp-and-tie technique 182
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 182
The effect of robot-assisted transaxillary thyroidectomy (RATT) on body image is better than the conventional approach with cervicotomy: a preliminary report 181
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 178
The extent of surgery in thyroglossal cyst carcinoma 176
Minimally invasive video-assisted thyroidectomy (MIVAT) 176
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 175
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 175
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 175
Video-assisted thyroidectomy: indications and results 174
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 174
Selective use of vandetanib in the treatment of thyroid cancer 173
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 171
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 169
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 169
Silent Pheocromocytoma presenting as tako-Tsubo syndrom during anesthesiological stress. 168
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 168
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 168
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 167
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. 167
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 167
Conservative management of a tracheal leakage occurring 40 days after robotic thyroidectomy 167
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 166
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 166
Cabozantinib in Thyroid Cancer 164
Track Recurrence after Robotic Transaxillary Thyroidectomy: A Case Report Highlighting the Importance of Controlled Surgical Indications and Addressing Unprecedented Complications 162
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 162
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 161
null 160
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 160
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 159
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 159
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 158
Minimally Invasive Videoassisted thyroidectomy 158
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 158
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 158
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 158
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 158
Endoscopic Parathyroidectomy 157
null 157
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 157
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases 155
Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules: An Efficient and Safe Alternative to Surgery 155
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 154
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 154
Minimally invasive approach to the cervical spine: a proposal 153
Postoperative Pain Evaluation After Robotic Transaxillary Thyroidectomy Versus Conventional Thyroidectomy: A Prospective Study 153
Cosmetic result and overall satisfaction after minimally invasive video-assisted thyroidectomy (MIVAT) versus robot-assisted transaxillary thyroidectomy (RATT): A prospective randomized study 153
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 153
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 152
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 152
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 152
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 151
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 151
Persistent primary hyperparathyroidism caused by an ectopic adenoma in the piriform sinus: case report and review of the literature 150
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 150
Impact of harmonic scalpel on operative time during video-assisted thyroidectomy 150
Tailored surgery according to molecular analysis in differentiated thyroid carcinomas 150
Peduncolated adenomas with invasive carcinoma removed endoscopically . Is it necessary surgical treatment? 149
Cardiovascular changes in patients with primary hyperaldosteronism after surgical or medical treatment 149
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 149
The necessity for a thoracic approach in thyroid surgery 148
Impact of energy-based devices in pediatric thyroid surgery 148
No Outcome Differences between a Laparoscopic and Retroperitoneoscopic Approach in Synchronous Bilateral Adrenal Surgery 147
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis 147
Adrenal surgery before and after the introduction of laparoscopic adrenalectomy 146
Novel treatments for anaplastic thyroid carcinoma 146
Totale 19.368
Categoria #
all - tutte 125.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.404 0 0 0 0 0 137 189 199 203 185 148 343
2021/20223.042 75 144 101 184 557 440 73 137 169 98 180 884
2022/20234.209 487 549 288 349 448 502 62 338 743 48 319 76
2023/20243.456 357 318 391 297 479 565 194 135 107 87 196 330
2024/202510.310 136 386 155 600 897 1.058 863 570 1.087 1.333 1.123 2.102
2025/20268.156 885 1.745 2.041 1.120 1.231 1.134 0 0 0 0 0 0
Totale 43.856